October 12, 2016
October 12 – World Arthritis Day
Arthritis is very common but is not well understood. Actually, “arthritis” is not a single disease; it is an informal way of referring to joint pain or joint disease.
pharmaceutical daily
Pharmaceuticals, Biotechnology and Life Sciences
October 12, 2016
Pharmaceutical daily wishes you happy and healthy holidays!!!
Pharmaceutical daily brings daily pharmaceutical news from all around the world. We scoop for information about clinical research, new products in…
October 12, 2016
Said Darwazah, Chairman and CEO of Hikma, awarded Global Generics “Leader of the Year”
Hikma Pharmaceuticals has announced that Said Darwazah, Chairman and Chief Executive Officer of Hikma, received the “Leader of the Year Award” at the Global Generics and Biosimilars Awards held in Barcelona on 4 October 2016.
October 12, 2016
Inspirational Portraits And Interviews Of Famous Women in Allergan’s ActuallySheCan campaign
ActuallySheCanSM, the female empowerment campaign by Allergan, has unveiled a striking series of portraits shot by celebrated photographers Inez van…
October 12, 2016
Ablynx, Merck further extend their collaboration on ion channel research, Ablynx gets €1M
Ablynx has extended for a second time its research collaboration with a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, known as MSD outside the United States and Canada, to develop and commercialise Nanobody candidates directed towards an undisclosed voltage gated ion channel.
October 11, 2016
ESMO 2016: Single-Arm Trials Improve Early Access to Rare Cancer Drugs
Although randomised clinical trials (RCTs) remain the gold standard for evaluating the benefit/risk of cancer drugs, single-arm trials (SATs) can provide invaluable opportunities to speed up cancer drug development and approval, in particular for drugs with dramatic activity and strong biological rationale in small populations with high unmet need, Dr. Jorge Martinalbo, Scientific Officer at the European Medicines Agency (EMA) reported at the ESMO 2016 Congress.
October 11, 2016
BIOPHYTIS to implement SARA-data e-Health platform
BIOPHYTIS, a biotechnology company specialized in the development of drug candidates to treat aging diseases, has announced the implementation of a proprietary e-Health platform, SARA-data, to process patient data from its SARA clinical studies.
October 11, 2016
FDA’s approval of NIcox’s cetirizine eye drop formulation triggers $35M in NIcox shares
The approval of the AC-170 NDA after December 1, 2016 would trigger a milestone payment of $10 million in Nicox shares to ex-Aciex shareholders or $35 million in Nicox shares if approval of the NDA is received before this date.
October 11, 2016
ABIVAX hostsR&D Day at its new laboratory in Montpellier
ABIVAX is hosting an R&D Day at the Company’s new collaborative laboratory with the French National Center for Scientific Research (CNRS) in Montpellier.
October 11, 2016
Biocartis’ Idylla technology could enhance molecular diagnostic testing
Biocartis Group NV, a Belgian innovative molecular diagnostics company has published a comparative study organised by AstraZeneca where 12 different KRAS mutation detecting technologies, including Next-Generation Sequencing (NGS) and quantitative Polymerase Chain Reaction (PCR), were compared for the detection of KRAS mutations in lung cancer, using blinded samples.